Warning letter
Triangle Compounding Pharmacy: warning letter of Dec 4, 2006
FDA warning letter UCM076193 · Atlanta District Office
Key facts
| Reference number | UCM076193 |
|---|---|
| Company | Triangle Compounding Pharmacy |
| Subject | Pharmacy Compounding/New Drug/Misbranded |
| Issue date | Dec 4, 2006 |
| Posted date | Dec 4, 2006 |
| Issuing office | Atlanta District Office |
| Product type | Drugs |
| CFR sections cited | 201.115 |
| Country | 3 |
| Inspection city | Cary |
| Inspection ZIP | 27518-8696 |
| Inspection start date | Feb 17, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: